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Wnt signaling plays an essential role in develop-
mental and regenerative myelination of the CNS;
however, contributions of proximal regulators of the
Wnt receptor complex to these processes remain un-
defined. To identify components of the Wnt pathway
that regulate these processes, we applied amultifac-
eted discovery platform and found that Daam2-
PIP5K comprise a novel pathway regulating Wnt
signaling and myelination. Using dorsal patterning
of the chick spinal cord we found that Daam2 pro-
motes Wnt signaling and receptor complex forma-
tion through PIP5K-PIP2. Analysis of Daam2 function
in oligodendrocytes (OLs) revealed that it sup-
presses OL differentiation during development, after
white matter injury (WMI), and is expressed in human
white matter lesions. These findings suggest a phar-
macological strategy to inhibit Daam2-PIP5K func-
tion, application of which stimulates remyelination
after WMI. Put together, our studies integrate infor-
mation from multiple systems to identify a novel
regulatory pathway for Wnt signaling and potential
therapeutic target for WMI.
INTRODUCTION
Oligodendrocytes (OLs) produceandassemble themyelin sheath,
which insulates axons in theCNSand facilitates saltatory conduc-
tion. Given their vital role in CNS physiology, loss of myelinating
OLscan result in several neurological disorders, includingmultiple
sclerosis (MS) in adults and cerebral palsy (CP) in children (Chang
et al., 2002; Franklin, 2002; Khwaja and Volpe, 2008; Woodward
et al., 2006). OLs have a robust capacity for regeneration (or re-
myelination), suggesting that endogenous cellular mechanisms
can be employed for repair of white matter injury (WMI). However,areas of WMI in both adults and children are populated by
‘‘stalled’’ OL precursors (OLPs), suggesting that the molecular
mechanismsgoverningOLPdifferentiation intoOLs issuppressed
by inhibitory signals within these lesions (Billiards et al., 2008;
Buser et al., 2012; Hammond et al., 2014; Kuhlmann et al.,
2008). Therefore, a comprehensive understanding of the molecu-
larmechanisms regulatingOLPdifferentiation intoOLsmay reveal
therapeutic strategies that stimulate remyelination after WMI.
A central tenet of regenerative biology is that restorative
processes parallel those found in development. Among the key
molecular processes that suppress OLP differentiation during
development and after WMI is Wnt signaling. Chronic activation
of canonical Wnt signaling in OLPs results in delayed develop-
mental and regenerative myelination (Emery, 2010; Fancy
et al., 2009, 2014; Tawk et al., 2011). These functional studies,
coupled with elevated expression of key pathway components
in OLP populations in human WMI, suggest that Wnt signaling
is a crucial regulatory node that is dysregulated after WMI and
a potential target for therapeutic intervention (Fancy et al.,
2011). Studies on Wnt signaling have focused on how key distal
transcriptional effectors of this pathway regulate OLP differenti-
ation; however, the contributions of the proximal membrane and
intracellular components that transduce these signals have not
been examined in this context. One critical aspect of Wnt signal
transduction is the clustering of Wnt receptor complexes into
signalosomes, which are required for the initiation, amplification,
and maintenance of Wnt signaling (Bilic et al., 2007; He et al.,
2004; MacDonald et al., 2009; Mao et al., 2001; Schwarz-
Romond et al., 2007). Wnt receptor signalosomes represent a
potential therapeutic target because they function at the cell
membrane and are therefore more accessible for pharmacolog-
ical manipulation. In spite of these potential therapeutic attri-
butes, the mechanisms that regulate Wnt receptor clustering
and subsequent signalosome formation remain uncharacterized
during OLP development and remyelination.
A key step in signalosome formation is the aggregation and
clustering of Frizzled/LRP/Dishevelled/Axin complexes, which
facilitates amplification and maintenance of Wnt signaling (Bilic
et al., 2007; Pan et al., 2008; Qin et al., 2009). Recently we foundNeuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc. 1227
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that Daam2 is required for canonical Wnt signaling during
patterning in the dorsal spinal cord, functioning through the clus-
tering and formation of Wnt receptor signalosomes (Lee and
Deneen, 2012). At the biochemical level, Daam2 promotes the
aggregation of Dishevelled (Dvl) complexes, which supports sig-
nalosome formation and potentiates Wnt activity. While these
studies implicate Daam2 as a vital component of the Wnt recep-
tor complex and provide a framework for understanding signal-
osome formation, the underlyingmechanisms of Daam2 function
remain poorly characterized.
During gastrulation the PIP5K-Ptdlns(4,5)P2 (PIP2) pathway
controls LRP5/6 phosphorylation and subsequent clustering of
Wnt receptor complexes (Pan et al., 2008). Activation of PIP5K
is regulated through its association with Dvl, in a Wnt3a-depen-
dent manner (Qin et al., 2009). That Daam2 synergizes with
Wnt3a in the dorsal spinal cord and also associates with Dvl sug-
gests a possible functional link with the PIP5K-PIP2 pathway
during Wnt signalosome formation in the CNS (Lee and Deneen,
2012). Importantly, a deeper mechanistic understanding of Wnt
signalosome formation can potentially offer novel therapeutic
insight into repair after WMI, as the role of Daam2 and its asso-
ciated biology in OLP populations during development and after
WMI remains completely undefined.
Using this premise as our starting point, we show that Daam2
regulates canonical Wnt signaling and signalosome formation
through the PIP5K-PIP2 axis. Examination of Daam2 function
during OLP development revealed that it suppresses their differ-
entiation into OLs. These developmental findings were subse-
quently applied to WMI, where we found that Daam2 is similarly
expressed in OLPs in human white matter lesions and functions
to suppress their differentiation in mouse models of WMI. Our
mechanistic studies suggested that pharmacological inhibition
of PIP5K function might be an approach to suppress the Wnt
pathway in OLPs. Translation of these findings to our WMI
models revealed that inhibition of PIP5K promotes OLP differen-
tiation in vitro and remyelination during in vivo regeneration.
Together, these data identify a novel mechanism that regulates
Wnt signaling in OLPs and point to a potentially new therapeutic
approach for stimulating myelin repair after WMI.
RESULTS
Daam2 Regulates Canonical Wnt Signaling through
PIP5K-PIP2
Previous studies have linked PIP2 production to Wnt signalo-
some formation (Pan et al., 2008). Given that Daam2 regulatesFigure 1. Daam2 Regulates Dorsal Patterning and Canonical Wnt Sign
(A–D) Chick spinal cord electroporated with Daam2-shRNAi (or mutant control), P
localization of GFP reporter, indicating PIP2 activity.
(F) PIP2-ELISA on spinal cord electroporated with Daam2-shRNAi or mutant con
(K–N) Overexpression of PIP5K rescues dorsal patterning and canonical Wnt si
denote reduced dorsal marker expression (Pax7, TOP-nRFP), open arrowheads
(O–Q) Quantification of dorsal patterning (Pax7), canonical Wnt activity (TOP-nRFP
four independent embryos, six sections per embryo.
(R–U) Co-expression of Daam2/Dvl3 results in clustering; siRNA knockdown of P
(Z–EE) Treatment with Sp-8-pCPT-cAMPs inhibits assembly of Daam2/Dvl3 com
(U), (Y), (BB), and (EE), respectively, and are representative of 50 such measurem
harvested at E4. Error bars in all graphs are SD (*p < 0.005; **p < 0.01; in P–R compsignalosome formation, we assessed whether it regulates PIP2
activity in chick spinal cord by co-electroporating Daam2-
shRNAi (or mutant shRNAi control) with a PLCd-PH-GFP re-
porter, which binds PIP2 and reports its intracellular localization
(Balla and Va´rnai, 2002). We found that knockdown of Daam2 re-
sults in decreasedmembrane localization of the reporter (Figures
1A and 1B versus 1C–1E). In parallel, we performed a PIP2 ELISA
assay on these chick spinal cords and found a drastic decrease
in PIP2 production in the presence of the Daam2-shRNAi (Gray
et al., 2003; Pan et al., 2008) (Figure 1F); together these data indi-
cate that knockdown of Daam2 results in decreased production
of PIP2. Further biochemical analysis of these interrelationships
using in vitro lipid binding assays (Heo et al., 2006) indicates
that Daam2 does not directly associate with PIP2 (Figures
S1A–S1F), suggesting an indirect regulatory relationship.
The production of PIP2 is regulated by PIP5K (van den Bout
and Divecha, 2009), raising the possibility that Daam2 regulates
PIP2 production, and Wnt signaling, through PIP5K. To test
this hypothesis, we examined whether PIP5K overexpression
rescues dorsal patterning and canonical Wnt signaling in the
absence of Daam2. As indicated in Figure 1, co-electroporation
of PIP5Kwith the Daam2-shRNAi restored canonical Wnt activity
and dorsal patterning in the developing spinal cord (Figures 1G–
1P). Moreover, ELISA assay analysis shows that PIP5K rescued
PIP2production, furthercorrelatingDaam2-dependentWntactiv-
ity to PIP2 production (Figure 1Q). To confirm the role of PIP5K in
Wnt signaling, we performed shRNAi knockdown in chick and
found a loss of dorsal patterning and Wnt signaling, phenotypes
that parallel knockdown of Daam2 (Figures S1G–S1U). To estab-
lish the functional relationship between Daam2 and PIP5K during
Wnt signalosome formation we used in vitro clustering assays
(Bilic et al., 2007; Lee and Deneen, 2012). siRNA knockdown of
PIP5K completely blocked the clustering of Wnt receptor com-
plexes mediated by Daam2, reinforcing their cooperative rela-
tionship during the construction of Wnt receptor complexes at
the cellular level (Figures 1R–1Y; see Figures S1V and S1W).
Daam2 and PIP5K Biochemical Interaction Regulates
Wnt Signaling
Further examination into their relationship revealed that Daam2
and PIP5K co-immunoprecipitation (coIP) and subsequent
GST pull-down studies confirmed that they directly interact (Fig-
ures 2A and 2B). Investigation into the nature of the biochemical
relationship between Daam2 and PIP5K revealed that the
Daam2-GBD domain and the N-terminal region of PIP5K are
required for their associations (Figure 2C, lane 2; Figure 2D,aling through PIP5K-PIP2 Signaling
LCg-PH-GFP reporter, and TOP-nRFP (red). Arrow in (B) denotes membrane
trol. Quantification in (E) and (F) is from four independent experiments.
gnaling in the absence of Daam2; (G–J) Daam2-shRNAi control. Arrowheads
denote ventral markers with no change (Nkx2.2).
), and PIP2 production from chick experiments; values are derived from at least
IP5K (V–Y) inhibits assembly of Daam2/Dvl3 complexes.
plexes. Dashed lines in (R), (V), (Z), and (CC) are line intensity graphs shown in
ents. Ep, electroporated side; Con, control side. All chick experiments were
arisons are between D2i and D2i/PIP5K conditions). Please also see Figure S1.
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Figure 2. Structural Analysis of Daam2 and PIP5K Biochemical Interaction
(A and B) Immunoblots of HEK293 cell extracts expressing Myc-Daam2 and co-immunoprecipitating endogenous PIP5K; GST pulldown studies with GST-
tagged PIP5K and FLAG-tagged Daam2.
(C) CoIP experiments between HA-tagged PIP5K and various Daam2 mutants listed.
(D) CoIP experiments between Myc-tagged Daam2 and various PIP5K mutants listed.
(legend continued on next page)
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lane 3). These results suggest that theN-terminal region of PIP5K
is required for its function toward Wnt signaling. To test this, we
performed rescue analysis of Daam2-shRNAi with the PIP5K
mutants in the chick spinal cord, finding that the PIP5K mutants
lacking either the N terminus (DN) or the kinase domain (DKD) do
not rescue Wnt signaling or dorsal patterning, while the C-termi-
nal deletion (DC) does (Figures 2E–2R). These data indicate that
the kinase and the N-terminal domains of PIP5K are required
for its function in this context. Another key finding from our
biochemical studies is that the Daam2-GBD domain is required
for its interaction with PIP5K (Figure 2C, lane 2). Importantly,
the GBD domain is essential for interactions with Rho-GTPases,
which also associate with Daam2 (Figure S1Y). These observa-
tions, put together with previous studies demonstrating that
Sp-8-pCPT-cAMPs (cAMP) inhibit PIP5K activity through Rho
signaling (Yang et al., 2004), suggest an approach for inhibiting
Daam2/PIP5K function. To examine whether this pharmacolog-
ical approach similarly suppresses Wnt signaling in the spinal
cord, we cultured chick spinal cord explants (see Figure 2S)
with Sp-8-pCPT-cAMPs. Analysis revealed a selective loss of
dorsal markers and canonical Wnt signaling, which is likely due
to reduced PIP5K activity, as PIP2 production is also drastically
reduced (Figures 2T–2Z). Finally, treatment with Sp-8-pCPT-
cAMPs blocked Daam2-mediated Wnt receptor clustering (Fig-
ures 1Z–1EE and S1X). Collectively, these data indicate that
Daam2 regulatesWnt signaling through PIP5K-PIP2 and suggest
that inhibition of this pathway suppresses Wnt signaling in the
developing CNS.
Daam2 Suppresses OLP Differentiation during
Development
To investigate a potential role for Daam2 in glial populations we
characterized its expression patterns during gliogenesis in the
developing and post-natal spinal cord. To determine the extent
of its expression in the OL and astrocyte lineages, we assessed
its co-expression with markers of these glial lineages in the
developing spinal cord of a Daam2LacZ/+ mouse we recently
generated (Figure S2; see Supplemental Information). Analysis
of Daam2 expression at E18.5 revealed co-localization with
Olig2 in OLPs and GLAST in astrocyte precursors (ASPs) (Fig-
ures 3A and 3B). Daam2 expression was also detected in OL
and astrocyte populations (Figures 3C and 3D). These findings
were corroborated by double in situ hybridization (Figures
S3A–S3H). Analysis in the adult spinal cord revealed similar
expression patterns (Figures 3E–3H). These data indicate that
Daam2 is expressed in bothOL and astrocyte lineages in the em-
bryonic and adult spinal cord.
That Wnt signaling plays a vital role in suppressing OLP differ-
entiation, and Daam2 is a key regulator of Wnt signaling, raises(E–R) Rescue analysis of various PIP5K mutants in chicks co-electroporated wit
(S) Schematic of chick explant system.
(T–W) Chick spinal cord was electroporated with TOP-nRFP andGFP control and
TOP-nRFP reporters in the presence of Sp-8-pCPT-cAMPs. Open arrowhead de
(X and Y) Quantification of dorsal (Pax7) and ventral (Nkx2.2) patterning and canon
least four independent embryos, six sections per embryo.
(Z) PIP2 ELISA on chick explants treated with Sp-8-pCPT-cAMPs; values are deriv
side. All chick experiments were harvested at E4. Error bars are SD, and *p < 0.0the possibility that Daam2 may regulate OLP differentiation. To
test this, we overexpressed Daam2 in the embryonic chick spinal
cord and found a reduction in the number of MBP- and PLP-ex-
pressing cells at E11 (Figures 3I, 3K, and 3O; see Figures S3Z–
S3CC for high-magnification images). Importantly, this was
coupled with no change in the number of OLPs or ASPs, indi-
cating the suppression of OL differentiation by Daam2 is not
due to a loss of OLP populations or interconversion of glial
sub-lineages (Figures 3L–3N and 3P). Next, we assessed OL
differentiation in the spinal cord of Daam2 knockout mice (see
Figure S2), finding that loss of Daam2 results in the precocious
differentiation of MBP- and PLP-expressing OLs at P0 (Figures
4A and 4B versus 4D, 4E, 4G, and 4H; see Figures S3DD–
S3GG for high-magnification images). This effect is not second-
ary to changes in the constituency of other glial lineages, as there
were no differences in the number of OLPs (Figure 4C versus 4F
and 4I) or astrocytes between Daam2+/ and Daam2/ mice
(Figures S4A and S4B). Subsequent analysis at later post-natal
time points revealed that the levels of MBP and PLP expression
were comparable between the Daam2+/ and Daam2/,
indicating that Daam2 is required for the proper timing of OLP
differentiation (Figures S4C–S4J). To confirm that loss of
Daam2 accelerates OLP differentiation, we generated OLP
cultures from Daam2+/ and Daam2/ embryos. A total of
3 days after induction of differentiation, we found a drastic in-
crease in the number of MBP- and PLP-expressing cells in the
Daam2-knockout cultures (Figures 4J and 4K versus 4M, 4N,
4P, and 4Q), with no effect on the expression of OLP markers
(Figure 4L versus 4O and 4R). Consistent with a role in the timing
of differentiation, a similar, albeit less drastic, enhancement of
OLP differentiation was witnessed 7 days post-differentiation
(Figures S4K–S4P). Together, these gain- and loss-of-function
studies indicate that Daam2 suppresses OLP maturation by
regulating the time course of their maturation into MBP- and
PLP-expressing OLs.
Daam2 Suppresses OLP Differentiation through PIP5K
Having established that Daam2 regulates Wnt signaling through
the PIP5K-PIP2 axis (see Figures 1 and 2), we next examined
whether Daam2 functions through this mechanism to suppress
OLP differentiation. Using double in situ hybridization, we found
that Daam2 and PIP5K are co-expressed in the post-natal spinal
cord, and that PIP5K is similarly expressed in OLP populations in
the spinal cord (Figure S3). To determine whether PIP2 produc-
tion is dysregulated in the absence of Daam2, we transfected
OLPs generated from Daam2+/ and Daam2/ embryos with
the PLCd-PH-GFP reporter, finding reducedmembrane localiza-
tion, coupled with diffuse, cytosolic distribution of the reporter in
the absence of Daam2 (Figures 4S and 4T versus 4U and 4V).h Daam2-shRNAi.
grown as an explant. Arrows in (T)–(W) indicate reduced expression of Pax7 and
notes Nkx2.2 expression.
ical Wnt activity (TOP-nRFP) from these experiments; values are derived from at
ed from three independent experiments. Ep, electroporated side; Con, control
06; **p < 0.0004; ***p < 0.05. Please also see Figure S1.
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Figure 3. Daam2 Is Expressed in Glial Lineages and Suppresses OLP Differentiation in the Developing Spinal Cord
(A–H) Double immunofluorescence on spinal cord from Daam2LacZ/+ mice at E18.5 and 2 months of age. Please see Figure S2 for double in situ hybridization
images of Daam2 and the relevant glial lineage markers. Dashed lines in (A)–(D) demarcate white matter (WM).
(I–N) Overexpression of Daam2 in the chick spinal cord suppresses OLP differentiation at E11. (I) Ectopic Daam2 expression is detected with a-Myc. (J–K)
analysis of OL markers, (L) OLP populations, and (M–N) astrocyte precursors. Arrows in (J)–(K) denote reduced OLmarker expression on the electroporated side
(Ep) of the spinal cord.
(O and P) Quantification of the number of MBP-, PLP-, and PDGFRa-expressing cells, derived from at least eight sections from three E11 chick embryos. Ep,
electroporated side; Con, control side. Error bars are SD (*p < 0.005; **p < 0.01). Please also see Figures S2 and S3.This effect is consistent with reduced membrane production of
PIP2 and parallels our results in the chick spinal cord. Given
the link between PIP2 production and Wnt signaling (Figure 1)
(Pan et al., 2008; Qin et al., 2009), we sought to correlate these
changes in OLP differentiation and membrane production of
PIP2 to Wnt activity. To this end we measured Wnt activity in
Daam2+/ and Daam2/ OLPs by transfecting them with the
TOP-nRFP Wnt reporter (Lee and Deneen, 2012). Subsequent
analysis revealed a significant reduction in the number of cells re-1232 Neuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc.porting Wnt activity in Daam2/ OLP populations (Figure 4T
versus 4V and 4X). These results parallel those found during
patterning of the embryonic spinal cord (see Figure 1) and sug-
gest a direct mechanistic link between the Daam2-PIP2 axis
and Wnt signaling in OLPs.
To extend this model and establish a direct link between
Daam2 and PIP2 in OLPs we next determined whether Daam2
suppresses OLP differentiation through PIP5K by examining
whether overexpression of PIP5K in Daam2/ OLP populations
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Figure 4. Loss of Daam2 Stimulates OLP Differentiation during Development
(A–F) Analysis of P0 spinal cord fromDaam2+/ andDaam2/mice reveals increased expression of OLmarkers in the absence of Daam2 (arrows). There were no
changes in the number of cells expressing the OLP marker PDGFRa (C, F) or markers of other glial lineages (see Figure S3).
(G–I) Quantification of OL and OLP markers is derived from at least six sections, from three animals of each genotype.
(J–R) In vitro analysis of OL differentiation using Daam2+/ and Daam2/ OLP cultures at 3 days post-differentiation revealed increased expression of OL
markers (arrowheads in M and N).
(S–W) Daam2+/ or Daam2/ cultures were transfected with the PLCg-PH-GFP reporter (PIP2-GFP) and TOP-nRFP (red), revealing reduced membrane pro-
duction of PIP2 (arrows in S and U) and Wnt activity (arrows in T and V) in the absence of Daam2.
(X) Quantification of Wnt activity in Daam2/ OLPs.
(Y–CC) In vitro analysis of OLP cultures treated with Sp-8-pCPT-cAMPs (cAMP), analyzed at 3 and 7 days after induction of differentiation. The quantification for
all in vitro studies is derived from two independently derived sets of cultures and is representative of three experiments, performed in triplicate. Error bars are SD
(*p < 0.005; **p < 0.01). Please also see Figures S2–S4.is sufficient to block accelerated OLP differentiation. Toward
this, Daam2/ OLPs were infected with lentivirus containing
Cherry or PIP5K and harvested at 3 and 7 days after the induc-
tion of differentiation. Analysis of OL differentiation revealed
that PIP5K overexpression blocked the precocious and
enhanced appearance of MBP- and PLP-expressing cells in
Daam2/ OLPs (Figures S4Q–S4U). These effects of PIP5K
were not due to a loss of OLP populations, as the number of
Olig2-expressing cells was unchanged, and indicates that
Daam2 function during OLP differentiation is mediated in partthrough PIP5K and, again, parallels our observations from the
chick spinal cord (Figure 1). That Daam2 signals through the
PIP5K-PIP2 axis during OLP differentiation suggests that inhibi-
tion of this signaling axis may similarly promote OLP maturation.
To test this possibility, we generated OLPs from embryonic spi-
nal cord and added Sp-8-pCPT-cAMPs after induction of differ-
entiation. Analysis at 3 and 7 days post-differentiation revealed
precocious and enhanced OL differentiation, marked by expres-
sion of MBP, coupled with no changes in the number of OLPs
(Figures 4Y–4CC). These findings suggest that Daam2 functionsNeuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc. 1233
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Figure 5. Daam2 Suppresses OLP Differentiation after WMI
(A and B) Co-expression of Daam2-LacZ and Olig2 at 7 dpl in a mouse lysolecithin lesion.
(C) Schematic of the loss-of-function (LOF) and gain-of-function (GOF) paradigms.
(D–K) Loss of Daam2 results in increased expression of OL markers at 7 dpl, without affecting the number of OLPs.
(L–S) Viral overexpression of Daam2 suppresses the expression of OL markers at 12 dpl; overexpression of Daam2 in lesions did not affect the number of OLPs.
Dashed lines in (D)–(S) indicate lesion borders.
(T–W) Quantification of OL and OLPmarker expression in LOF andGOF experiments. For the LOF analysis, experiments were performed on at least three animals
per genotype, and quantification involved at least eight sections per animal. For the viral GOF analysis, experiments were performed on at least six animals per
condition, and quantification involved at least eight sections from three animals demonstrating the highest expression of the respective viral transgene. Error bars
are SD (*p < 0.005; **p < 0.01). Please also see Figure S5.through PIP5K and implicate PIP5K-PIP2 signaling in the sup-
pression of OLP differentiation.
Daam2 Suppresses OLP Differentiation after WMI
Our foregoing data describing the ability of Daam2 to suppress
OLP differentiation in developmental systems led us to investi-
gate whether it has a similar function during remyelination after
WMI in the adult spinal cord. Toward this objective, we examined
Daam2 expression and function in a lysolecithin model of WMI, a
well-established gliotoxic injury model that allows for the precise
evaluation of remyelination repair kinetics (Figure S5A) (Fancy
et al., 2009). Using the Daam2-LacZmouse, we performed lyso-
lecithin lesioning on adult spinal cord, finding that Daam2 is
indeed expressed in OLP populations at induced lesion sites
(Figures 5A and 5B). To address whether Daam2 similarly sup-
presses OLP differentiation during remyelination, we next per-
formed lysolecithin lesioning on Daam2+/ and Daam2/ mice
and analyzed the extent of OLP differentiation at 7 days post
lesion (dpl), a time point that precedes normal remyelination
and is devoid of mature OL populations (Figures 5C and S5).1234 Neuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc.Analysis of OLP differentiation inDaam2 knockout mice revealed
a 5-fold increase in the number of MBP- and PLP-expressing
cells compared to heterozygote controls (Figures 5E and 5F
versus 5I, 5J, and 5T), without any effect on the number of
Olig2-expressing cells (Figures 5G, 5K, and 5U). Additionally,
the reactive astrocyte and inflammatory responses are unaf-
fected by the loss of Daam2 (Figures S5B–S5E). These data indi-
cate that Daam2 suppresses OLP differentiation after WMI.
Nextweperformed thecomplementary gain-of-functionexper-
iments in the lesioned spinal cord. For this, the spinal cords of
wild-type mice were subjected to lysolecithin lesioning and fol-
lowed by a secondary injection of lentivirus containing GFP or
Daam2-IRES-GFP at 3 dpl, during the height of OLP recruitment
to the lesion (Figure 5C, bottom). Because we anticipated that
Daam2 overexpression would suppress OLP differentiation, we
evaluated lesions at 12 dpl, a time point where a significant num-
ber of OLPs have differentiated into OLs. As expected, the GFP
control showed extensive OL differentiation (Figures 5M and
5N), while the lesions injected with the Daam2-containig
virus exhibited a drastic decrease in the number of MBP- and
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Figure 6. Inhibition of PIP5K Activity Promotes Remyelination after WMI
(A and B) In situ hybridization demonstrating co-expression of PIP5K and PDGFRa at 7 dpl in a mouse lysolecithin lesion.
(C) Schematic of experimental paradigm.
(D–K) Treatment with Sp-8-pCPT-cAMPs results in increased expression of OL markers at 7 dpl, compared to the vehicle control, without affecting the number
of OLPs.
(L and M) Quantification of OL and OLP marker expression was performed on at least eight sections from six mice per condition (Sp-8-pCPT-cAMPs or control).
Error bars in graphs are SD.
(N–P) Myelin formation was assessed using electron microscopy (EM) on 70-nm sections from lesions at 10 dpl. This analysis revealed significant increases in the
thickness of the restored myelin sheaths (t test, p = 0.0043); G-ratios were significantly different between the control (G-ratio = 0.904, SEM = 0.004) and the Sp-8-
pCPT-cAMPs groups (G-ratio = 0.860, SEM = 0.003). EM and G-ratio analysis was performed on three animals per condition. Scale bar in (N), 2 mm. *p < 0.005;
**p < 0.01. Please also see Figure S6.PLP-expressing OLs (Figures 5Q, 5R, and 5V). This decrease
in OL differentiation was not the result of diminished OLPs or
changes in the reactive astrocyte response, since the number of
Olig2- and GFAP-expressing cells was not affected by Daam2
overexpression (Figures 5O, 5S, 5W, and S5F–S5I). Together
these studies indicate thatDaam2suppressesOLPdifferentiation
after WMI and, in conjunction with our previous studies, reveal
that its function is conserved across development and repair.
Inhibition of PIP5K Stimulates Remyelination after WMI
Our discovery that Daam2 functions through the PIP5K-PIP2 axis
to regulate Wnt signaling and OLP differentiation, coupled with
the role of Daam2 in repair after WMI, suggest that this mecha-
nism is similarly reutilized during repair after WMI. This notion
is further supported by our observation that PIP5K is expressed
in OLP populations in lysolecithin-induced white matter lesions
(Figures 6A and 6B). Moreover, because PIP5K is expressed in
these lesions, and there is an associated pharmacological agent
that inhibits its activity, this pathway may represent a therapeu-
tically actionable target for white matter disorders. Indeed, Sp-
8-pCPT-cAMPs suppresses Wnt signaling (Figure 1W) and pro-
motes OLP differentiation (Figures 4Y–4CC), suggesting that it
may similarly stimulate remyelination after WMI. Application of
this biology toward repair afterWMI is critical, as there is a dearthof pharmacological strategies that promote OLP differentiation
after injury (see Discussion).
To determine the effects of inhibiting PIP5K activity on post-
injury remyelination, we co-injected lysolecithin with Sp-8-
pCPT-cAMPs (or vehicle control) into the spinal cord of wild-
type mice, harvesting lesioned spinal cords at 3 dpl and 7 dpl
(Figure 6C). Analysis at 3 dpl revealed the presence of a demye-
linated lesion, populated with Olig2-expressing OLPs in both Sp-
8-pCPT-cAMPs and control conditions, indicating that treatment
with Sp-8-pCPT-cAMPs does not interfere with lesioning or
recruitment of OLPs to the lesion site (Figures 6I–6P). Moreover,
the reactive astrocyte and inflammatory responses were unaf-
fected (Figures S6A–S6D). Next, we analyzed lesioned spinal
cord at 7 dpl, a time point that is normally devoid of differentiated
OLs, and observed a drastic increase in PLP- and MBP-positive
cells at the lesion site in the presence of Sp-8-pCPT-cAMPs
compared to vehicle (Figures 6E and 6F versus 6I, 6J, and 6L).
The OLP, reactive astrocyte, and inflammatory responses were
unaffected (Figures 6G, 6K, 6M, and S6E–S6H). These data indi-
cate that inhibition of PIP5K promotes OL differentiation after
WMI. To further substantiate these findings, we next performed
transmission electron microscopy (EM) analysis on the vehicle
and Sp-8-pCPT-cAMPs-treated lesions harvested at 10 dpl to
assess the formation of compacted myelin. Our EM analysisNeuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc. 1235
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Figure 7. Daam2-PIP5K Signaling Suppresses Myelination after Hypoxia
(A) Schematic of ex vivo remyelination experimental paradigms.
(B–E) Ex vivo cerebellar slices were prepared and treated with lysolecithin and subjected to Daam2 virus or Sp-8-pCPT-cAMPs.
(F–I) Ex vivo sliceswere prepared, subjected to acute hypoxia, and then treatedwith Daam2 virus or Sp-8-pCPT-cAMPs. Subsequently, the slices were harvested
and stained for MBP and Cspr. These experiments were performed three independent times, in triplicate; the figures are representative. Please also see
Figure S6.revealed a substantial increase in myelin thickness in lesions
treated with the Sp-8-pCPT-cAMPs compared to vehicle control
(Figures 6N–6P), indicating that the precocious OL differentiation
manifests in enhanced myelin formation (i.e., smaller G-ratios,
see Figure 6 legend). Together these data indicate that inhibition
of PIP5K stimulates remyelination after WMI and identifies this
pathway as a potential therapeutic target for WMI.
Daam2-PIP5K Signaling Axis Suppresses Remyelination
after Hypoxic Injury
In the lysolecithin injury model, our pharmacological and viral
manipulations are administered to the lesion site raising the pos-
sibility that they indirectly stimulate OL differentiation and remye-
lination through non-CNS-derived inflammatory cells or reactive1236 Neuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc.astrocytes. To examine this possibility we performed both viral
andpharmacologicalmanipulations in ex vivo cerebellar slice cul-
tures after lysolecithin demyelination, a well-established system
for modeling remyelination ex vivo (Birgbauer et al., 2004; Huang
et al., 2011). Here, we made cerebellar slices, and treated them
with lysolecithin to induce demyelination; 2 days later Daam2-vi-
rus (or control) or Sp-8-pCPT-cAMPs (or control) was added (Fig-
ures 7A and S6U–S6X). Analysis of OL differentiation after viral or
drugaddition revealed thatoverexpressionofDaam2 inhibitedOL
differentiation, while treatment with the Sp-8-pCPT-cAMPs stim-
ulated OL differentiation (Figures 7B–7E). These findings parallel
our in vivo results and indicate that the effects of our viral and
pharmacological manipulations are not mediated through non-
CNS inflammatory or reactive astrocyte populations.
In addition to lysolecithin-induced remyelination, the ex vivo
cerebellar system can also be used to model WMI following hyp-
oxia (An et al., 2011; Fancy et al., 2011). Toward this, cerebellar
slices were established andmaintained at 1%oxygen for 2 days,
after which there was a complete loss of mature OL populations
(Figures S6Q and S6R). After this acute hypoxia, the cultures
were returned to normoxia and treated with either the Daam2-
virus or Sp-8-pCPT-cAMPs (Figures 7F–7I, S6Y, and S6Z).
Subsequent analysis of OL regeneration revealed that Daam2
overexpression blocked OL differentiation, while Sp-8-pCPT-
cAMPs stimulated both OL differentiation (MBP) andmyelination
(Cspr) in these cultures.
That Daam2 is sufficient to suppress myelination after acute
hypoxia ex vivo led us to determine whether it has a similar
function in a neonatal model of hypoxic injury (HI). Established
models of neonatal HI involve placing pups and nursing mothers
in 10.5% oxygen from P3 to P11, which results in the loss of
OLs, followed by a period of regeneration during perinatal devel-
opment (Figure 8A) (Scafidi et al., 2014). We generated litters
containing Daam2+/ and Daam2/ pups and subjected them
to HI from P3 to P11. Analysis of OL differentiation in P18 brains
revealed significant increases in OL differentiation (MBP) and
myelination (CASPR) in the Daam2/ mice (Figures 8B–8E),
without changes in the number of Olig2-expressing cells (Fig-
ures S7F and S7G). Next we performed the complementary
gain-of-function studies by combining in utero electroporation
(IUE) of the cortex with PiggyBac-mediated gene expression.
Standard IUE approaches do not allow for long-term expression
because the plasmids do not integrate; here we used a dual
PiggyBac system that allows for plasmid integration, facilitating
long-term expression (Figures 8A and S7A) (Chen and LoTurco,
2012; Glasgow et al., 2014). As indicated in Figures 8F–8I, over-
expression of Daam2 resulted in decreased expression of MBP
and CASPR on the electroporated side of the cortex, coupled
with no changes in the number of Olig2-expressing cells (Fig-
ures S7H and S7I). These findings, combined with our ex vivo
studies, provide evidence that Daam2-PIP5K signaling sup-
presses myelination after HI and further consolidates the key
contributions of this signaling axis in the suppression of remye-
lination after WMI.
Daam2 and PIP5K Are Expressed in OLPs in Human
White Matter Disorders
Collectively, our findings implicate the Daam2-PIP5K pathway
as playing a key role in OLP differentiation during regenerative
myelination after gliotoxic injury in the adult and HI in neonates.
To determine whether this pathway is present in human WMI
associated with neonatal HI we investigated whether Daam2
and PIP5K are expressed in OLP populations within the
subcortical white matter of human neonatal brain damaged by
hypoxic-ischemic encephalopathy (HIE). HIE was diagnosed as
previously described based on both clinical and neuropatholog-
ical correlations (Fancy et al., 2011). Using in situ hybridization
for human PIP5K (Figure 8J) or Daam2 (Figure 8L), in combina-
tionwith immunostaining for Olig2 (Figures 8K and 8M), we found
that both PIP5K and Daam2 are expressed in OLP populations in
areas of gliotic subcortical whitematter. These findings, together
with our functional studies, suggest that the Daam2-PIP5Kpathway contributes to the suppression of remyelination after
human WMI.
DISCUSSION
In this study we used dorsal patterning in the embryonic chick
spinal cord as a discovery platform to delineate a novel mecha-
nism between Daam2 and PIP5K that regulates canonical Wnt
signaling during dorsal patterning of the spinal cord. Given that
Wnt signaling also plays a key role in suppressing OLP differen-
tiation, we applied these findings toOL development and discov-
ered that Daam2 similarly suppresses OLP differentiation during
developmental and regenerative myelination. Examination of hu-
man HIE lesions revealed that Daam2 and PIP5K are expressed
in OLP populations, implicating their function in the suppression
of remyelination in human WMI. Furthermore, pharmacological
inhibition of PIP5K promotes OLP differentiation and stimulates
remyelination after WMI. These studies reveal a novel mecha-
nism regulating Wnt receptor complex formation that dictates
OLP development and regeneration, and in the process identi-
fied a potential therapeutic target for stimulating remyelination
after WMI.
New Mechanisms of Wnt Signalosome Formation in
the CNS
Mechanisms that regulate clustering of Wnt receptor complex
components and subsequent signalosome formation have re-
mained enigmatic. Herewe found that Daam2 regulates the clus-
tering of Wnt receptor signalosomes through its association with
PIP5K. Wnt signalosome formation by this complex is mediated
through PIP2, revealing a novel role for Daam2 in the regulation of
PtdIns lipids and at the same time providing critical new insight
into the regulation of PIP2 in canonical Wnt signaling (Figure 9).
Together these studies identify a novel pathway regulating the
construction of Wnt receptor signalosomes that directly influ-
ences two key Wnt-dependent processes in the CNS: (i) embry-
onic patterning of the dorsal spinal cord and (ii) differentiation
of OLP populations during developmental and regenerative
myelination.
In the course of our studies we found that PIP5K directly inter-
acts with Daam2 and rescuesWnt signaling and PIP2 production
in its absence. Deletion mapping of these proteins found that the
Daam2-GBD domain is required for association with PIP5K.
The nature of the Daam2/PIP5K interaction implicates Rho-
GTPases, as GBD domain is essential for these interactions,
which also associate with Daam2 (Figure S2). This biochemical
relationship, combined with previous studies implicating Rho
signaling in the inhibition of PIP5K function, paved the way for
our use of Sp-8-pCPT-cAMPs (see below). Besides the potential
use of these biochemical relationships as a potential target for
WMI, these observations raise several key mechanistic ques-
tions that will warrant further investigation, namely: how does
the Daam2/PIP5K complex regulate PIP2 production? The trans-
location of PIP5K to the membrane is a key regulatory step in the
production of PIP2, therefore it is possible that Daam2 facilitates
the membrane localization of PIP5K. Interestingly, the Daam2
associates with Rho-GTPases and Dishevelled, both of which
have been implicated in the translocation of PIP5K (HalsteadNeuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc. 1237
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Figure 8. Daam2 Suppresses Myelination after Neonatal Hypoxic Injury
(A) Schematic of neonatal mouse hypoxic injury (HI) model and our combined in utero electroporation (IUE) and dual PiggyBac (PB) overexpression system.
(B–E) Analysis of oligodendrocyte differentiation (MBP) and myelination (CASPR) in subcortical white matter regions from P18 Daam2+/ and Daam2/ mice.
(F–I) Complementary overexpression studies using the combined PB/IUE approach to overexpress Daam2. Inset in (G) is lower-magnification image showing the
region of the white matter demonstrating high ectopic expression of Daam2-t2a-GFP; see Figure S8. Analysis of oligodendrocyte differentiation at P18 revealed
decreased MBP and CASPR expression on the side of the cortex electroporated with the PB containing Daam2.
(J and K) PIP5K co-localizes with Olig2-expressing cells within human HIE white matter lesions.
(L and M) Daam2 co-localizes with Olig2-expressing cells within a human white matter lesion. Arrows denote cells co-expressing PIP5K or Daam2 and Olig2. Ep,
electroporated side; Con, control side. The knockout studies are representative of six animals from each genotype, derived from three independent litters. For the
PB/IUE experiments, the images are representative of five animals from two independent experiments. Please also see Figure S7.
1238 Neuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc.
Figure 9. Model for Daam2-PIP5K Function
in Wnt Signaling and Remyelination
Daam2 associates with PIP5K and promotes
the clustering of Wnt receptor complexes into
signalosomes through PIP2. The net result of
signalosome formation is the amplification and
maintenance of Wnt signal transduction, which in
OLP populations serves to suppress their differ-
entiation into myelinating OLs during development
and after WMI. Our pharmacological studies point
to the Daam2-PIP5K relationship as a potential
therapeutic node that could be used to screen for
inhibitors that disrupt Daam2-PIP5K interactions,
culminating in decreased levels of Wnt signaling
and increased OL generation after WMI. ** PIP2
phosphorylation of LRP6 was demonstrated pre-
viously in Xenopus (Pan et al., 2008).et al., 2010; Lee and Deneen, 2012; Pan et al., 2008). Together
these observations suggest that Daam2 serves as a trafficking
hub for PIP5K that ultimately regulates the levels of PIP2.
Daam2: A Novel Regulator of OLP Differentiation
Our studies on dorsal patterning in the embryonic chick spinal
cord directly implicate Daam2 and its associated biology in the
canonical Wnt pathway. Given that Wnt signaling plays a central
role in the suppression of OLP differentiation during develop-
ment, we extended our studies on Daam2 to the OL lineage.
Our overexpression and mouse knockout studies indicate that
Daam2, similar to other positive regulators of the Wnt pathway,
suppresses OLP differentiation during development and after
WMI. Together, these studies represent the first characterization
of Daam2 function in glial lineages during development and after
human WMI injury. Furthermore, these studies indicate that
proximal regulators of the Wnt receptor complex regulate OLP
development, suggesting that modulating levels of Wnt signaling
at the receptor level may be a therapeutically tractable approach
for WMI (Figure 9) (also see below).
Characterization of Daam2 expression in the OL lineage re-
vealed that it is expressed in both OLPs and mature OL popula-
tions. This diverges from the expression patterns of other Wnt
pathway components, which are expressed in OLP populations,
and downregulated during differentiation into OLs. Many of
these other Wnt components are distal effectors of the pathway
and subject to strict feedback regulation (Fancy et al., 2011,
2014; Shimizu et al., 2005). Since Daam2 acts proximally, and
is not a distal Wnt pathway effector, it is unlikely to be subject
to the same strict levels of regulation. Indeed, overexpression
of activated b-catenin or Wnt3a does not affect expression of
Daam2, indicating that it is regulated in a Wnt-independent
manner (data not shown). That Daam2 is expressed in mature
OLs raises the question of what, if any, role it might have in these
populations. Given that its function is reliant on Wnt ligands andNeuron 85, 1227–1243receptor complex formation, it is possible
that it functions in a non-canonical
Wnt pathway in these cell populations.
Indeed, Daam2 regulates cytoskeletal dy-
namics throughWnt5a and non-canonicalWnt signaling in the developing gut (Welsh et al., 2013). More-
over, Daam1 was originally identified as a regulator of Wnt-
dependent planar cell polarity (PCP) during gastrulation and
has been linked to actin remodeling (Habas et al., 2001). While
the non-canonical Wnt pathway has not been implicated in OL
development or function, actin-cytoskeletal dynamics have
been implicated in CNS myelination (Kim et al., 2006; Waggener
et al., 2013; Wang et al., 2008). Another possibility is that Daam2
functions in OLs through the Akt pathway. Activation of Akt
requires the conversion of PIP2 to PIP3, and given the role of
Daam2 in PIP2 production, it’s possible that it indirectly contrib-
utes to Akt-dependent myelination in OL populations (Flores
et al., 2008; Narayanan et al., 2009; Norrme´n and Suter, 2013).
Analysis of the Daam2 knockout mouse revealed precocious
OLP differentiation, which is consistent with reduced Wnt activ-
ity. However, examination at later post-natal time points re-
vealed normalized OL numbers between knockout and control
animals, indicating that Daam2 is critical for the timing of OLP
differentiation. It is likely these effects are due to redundant
mechanisms in place to safeguard Wnt receptor complex integ-
rity during this sensitive period of lineage development. For
example, excess levels of Dvl can promote clustering and
restore canonical Wnt signaling in the absence of Daam2 in the
chick (Lee and Deneen, 2012). In the context of an OLP, it is likely
that loss of Daam2 either influences the kinetics of Wnt receptor
complex formation, or its stability, the net result being a change
in the level of Wnt signals that are transduced. Such changes in
signaling levels culminate in the accelerated differentiation of
OLPs early in development. These observations indicate that
Daam2 function is required for the initiation of Wnt signaling
and hence is an ‘‘early/activating’’ event in the transduction of
the signal and ultimate activation of the pathway in OLPs.
Given these developmental dynamics and the functionally
redundant nature of the Wnt receptor complex, it is surprising
that manipulation of Daam2 expression has an effect on OLP, March 18, 2015 ª2015 Elsevier Inc. 1239
differentiation after WMI. While it is possible that Daam2 func-
tions in other cell populations present in lesions, our ex vivo
studies rule out non-CNS-derived cells, and manipulation of
Daam2 did not affect the constituency of reactive astrocytes,
suggesting its effects on OLP differentiation after WMI are cell
autonomous. Put together, these data suggest that remyelinat-
ing OLPs are sensitive to changes in the levels of Wnt signaling
and point to components of the Wnt receptor complex as poten-
tial therapeutic targets for WMI. This possibility is reinforced by
the expression of Daam2 and PIP5K in OLP populations in hu-
man HIE. Targeting members of this complex may be advanta-
geous because they function at the cell membrane and are
more accessible to pharmacological agents than transcriptional
or cytosolic effectors. Therefore a comprehensive understand-
ing of which components of the Wnt receptor complex are
expressed in remyelinating OLPs and the nature of their interac-
tions is essential in developing these therapeutic strategies.
Furthermore, it is likely that lesions contain a different constitu-
ency of Wnt ligands than during development, which will influ-
ence signalosome formation. Given the central role of Daam2
in this process, decoding how Wnt ligands present in lesions
regulate its signalosome organizing function will further guide
the development of these strategies.
New Therapeutic Pathways for WMI
Leveraging insight gained from our studies on dorsal patterning
in the embryonic chick spinal cord, we found that pharmacolog-
ical inhibition of PIP5K activity stimulates OLP differentiation
in vitro and provokes accelerated remyelination in animal and
ex vivo models of WMI in the adult spinal cord and neonatal
brain. These findings point to the Daam2-PIP5K-PIP2 signaling
axis as a potential therapeutic target for stimulating myelin
regeneration after WMI.
Here we used Sp-8-pCPT-cAMPs as a means to indirectly
inhibit PIP5K activity. This compound is a modified analog of
cAMP that contains a p-chlorophenylthio moiety, which signifi-
cantly enhances its lipophilicity (Schwede et al., 2000). This
chemical property likely facilitates its entry into cells and contrib-
utes, in part, to its ability to stimulate remyelination after injury
(Figure 5). That a one-time ‘‘pulse’’ injection of Sp-8-pCPT-
cAMPs coincident with lesioning can promote longer-term re-
myelination is striking. One explanation for these results is that
resident OLP populations within the white matter at the time of
lesioning are exposed to Sp-8-pCPT-cAMPs. Exposure of these
OLPs to the compound (facilitated by its lipophilicity) provokes
developmental changes (i.e., inhibition of Daam2/PIP5K and
Wnt) that stimulate their differentiation. Therefore, it is possible
that the acceleration of remyelination we witness after lysoleci-
thin lesioning is the result of exposing these resident OLP popu-
lations to this compound at the time of lesioning.
Prior studies on Sp-8-pCPT-cAMPs show that it functions
through Rho to inhibit translocation of PIP5K, which culminates
in impaired PIP2 production (Yang et al., 2004). These studies,
and the nature of the Daam2/PIP5K biochemical interaction
and function toward Wnt signaling, provided the rationale for
testing Sp-8-pCPT-cAMPs in this context. However, because
Sp-8-pCPT-cAMPs is a cAMP analog there are a few caveats
that must be considered. First, prior in vitro studies implicated1240 Neuron 85, 1227–1243, March 18, 2015 ª2015 Elsevier Inc.CREB activation in OLP differentiation, though whether these
effects are due to direct cAMP-PKA signaling remains poorly
defined (Raible and McMorris, 1989; Pende et al., 1997). Never-
theless, it is possible that the effects on OLP differentiation we
observe are due in part to direct activation by cAMP signaling.
Second, cAMP signaling can influence a wide range of pathways
that are also implicated in OLP differentiation (FGF/PDGF, IGF,
integrins) suggesting that the effects of Sp-8-pCPT-cAMPs
could also be mediated in part through these other pathways.
Despite these caveats, we show that treatment of both chick
explants and in vitro OLPs with Sp-8-pCPT-cAMPs resulted in
decreased PIP2 production and Wnt signaling, indicating that
it is functioning in part through these mechanisms in CNS and
OLP populations. Moreover, we also show that Sp-8-pCPT-
cAMPs blocks Wnt receptor clustering in vitro. Together, our
studies, across multiple systems, in conjunction with the obser-
vations from Yang et al. support the use of Sp-8-pCPT-cAMPs
as an indirect inhibitor of PIP5K andWnt signaling. These obser-
vations in fact highlight potential cross-talk between cAMP-Rho
and PIP5K-Daam2 signaling in the regulation of Wnt receptor
clustering and are key areas of future basic studies that have
critical translational implications for WMI and a host of other
Wnt-related diseases.
Similar to other pharmacological agents, this compound likely
has other ‘‘off-target’’ effects that will limit its efficacy in a clinical
setting. Moreover, because PIP5K-PIP2 and cAMP signaling
have wide-ranging effects on cell physiology (van den Bout
and Divecha, 2009), both inside and outside the CNS, it may
be therapeutically advantageous to develop agents that antago-
nize Daam2-PIP5K interactions, as this relationship may confer
specificity to the Wnt pathway in the CNS and/or OLP popula-
tions (Figure 9). Another potential regulatory node to target in
this context is the relationship between Rho-GTPases and
Daam2-GBD (Figure S1), as this interaction may also specifically
link PIP5K translocation and Wnt signaling. Finally, there is the
possibility that Sp-8-pCPT-cAMPs functions through astrocytes
or neurons to promote remyelination. This possibility seems un-
likely, because the effects we witness on myelination after injury
are very robust and occur immediately. Moreover, to our knowl-
edge, there is no prior evidence that promoting cAMP signaling
in neurons or astrocytes provokes a cell non-autonomous effect
after injury that drives robust remyelination in OLs after injury.
Therefore, the most parsimonious explanation for our injury re-
sults is that the compound is acting on OLP populations.
To our knowledge, there is only one other pharmacological
agent that stimulates OLP differentiation after WMI, XAV939,
which functions by inhibiting tankyrase activity, resulting in
stabilized Axin protein levels and suppression of Wnt signaling
(Fancy et al., 2011). Similar to Sp-8-pCPT-cAMPs, XAV939
acts indirectly on the Wnt pathway, and is likely to also influence
other signaling mechanisms. One therapeutic strategy to limit
potential ‘‘off-target’’ effects of both compounds might be to
combine them at sub-threshold levels and determine if they
synergistically suppressWnt activity and stimulate OLP differen-
tiation. Future studies will be directed toward combinatorial
approaches in vitro and in animal models to ascertain whether
these compounds synergistically stimulate OLP differentiation
and remyelination.
In spite of these limitations, our genetic and pharmacological
studies, spanning early embryonic development and adult
injury, indicate that the Daam2-PIP5K-PIP2 axis represents a
key regulatory node for Wnt signaling and an actionable
pathway for remyelination after WMI. The development of WMI
therapeutics based on this biology will require a deeper under-
standing of how Daam2 regulates PIP5K activity and PIP2
production and their associations in this context. Combining
tractable developmental models to dissect these mechanistic
relationships in vivo, with high-throughput drug screening
approaches that interfere with these relationships, may be an
efficacious, multi-disciplinary approach toward identifying new
clinical agents.
EXPERIMENTAL PROCEDURES
Mice
To generate the Daam2 knockout mice, we obtained the Daam2 tm1a (KOMP)
targeted ES cells, produced by the KOMP Repository (http://www.komp.org).
The Daam2 tm1a (KOMP) mouse line was generated by ES cell microinjection
in the ESCell Core Facility at the Baylor College ofMedicine (see Supplemental
Experimental Procedures). All procedures were approved by the Institutional
Animal Care and Use Committee at Baylor College of Medicine and conform
to the US Public Health Service Policy on Human Care and Use of Laboratory
Animals.
Constructs, siRNAs, and Pharmacological Treatments
Daam2 constructs used in this study have been described previously (Lee and
Deneen, 2012). Tagged cDNAs for human PIP5K were cloned into mammalian
expression vectors (33HA-pCS2+, 33FLAGpcDNA). The human andmouse
PIP5K siRNAs were designed using the siRNA Design Program (Dharmacon)
and synthesized by Thermo Scientific. The sequences of all of the siRNAs
are listed in Table S1. For pharmacological inhibition of PIP5K we used Sp-
8-pCPT-cAMPs (Sigma) (Yang et al., 2004).
In Ovo Electroporation and Chick Spinal Cord Explants Culture
Chick Daam2 and PIP5K shRNAi were cloned into avian retrovirus RCAS vec-
tors. The constructs were electroporated into the neural tube of stage 11 to
stage 13 chick embryos as described previously (Lee and Deneen, 2012).
For chick spinal cord explant culture, the electroporated chick embryos
were harvested and dissected using a micro tungsten needle to trim the spinal
cord in ice-cold PBS. Dissected spinal cord was moved into transwell plates
and maintained in DMEM/F12 with 0.1% fetal bovine serum (FBS) and N2
supplement for 48 hr.
In Situ Hybridization and Immunohistochemistry
Spinal cords were fixed in 4% paraformaldehyde and then cry-protected in
20% sucrose. To detect effective knockdown of Daam2 and PIP5K in the
chick, we generated mRNA probes and performed in situ hybridization (Lee
and Deneen, 2012). For chick spinal cord immunohistochemistry, the following
antibodies were used:mouse anti-Pax7 (DSHB), anti-Nkx2.2 (DSHB), anti-Myc
(Sigma), and rat anti-HA (Sigma). Mouse spinal cord was analyzed using
in situ hybridization: MBP, PLP, PDGFRa; and immunohistochemistry: chick
anti-beta galactosidase (Abcam 1:1,000), mouse anti-MBP (Covance 1:500),
mouse anti-PLP (1:500), rabbit anti-Olig2 (Abcam 1:1,000), rabbit anti-GFAP
(Dako 1:1,000), rabbit anti-Iba-1 (Dako 1:1,000).
OLP Culture
Oligosphere cultures were performed as previously described (Fancy
et al., 2012; Harrington et al., 2010). For viral infection of OLPs, cells
were dissociated and plated on poly-D-lysine-coated coverslips at a den-
sity of 1.5 3 104 cells/cm2 in oligodendrocyte precursor media (OPM)
subsequently infected with either PIP5K-lenti-cherry or control cherry fluo-
rescent protein virus for 14 hr. For Sp-8-pCPT-cAMPs studies, 100 mM ofdrug or vehicle control was added immediately after the induction of
differentiation.
Induction of Demyelination with Lysolecithin in Mouse Spinal Cord
and Viral Misexpression or Inhibitor Treatment in Remyelinating
Lesions
Lysolecithin-induced demyelinated lesions were generated in the white mat-
ter of the ventrolateral spinal cord of 8- to 10-week-old mice. Mice were har-
vested 3 days post lesion (dpl), 7 dpl, and 12 dpl, and analyzed. For viral
misexpression studies, the animal was injected with lysolecithin in white
matter lesion of spinal cord, followed by secondary focal injection of the
lesioned region with either a Daam2-containing lentivirus or control lentivirus
at 3 dpl. For these viral experiments, mice were perfused at 12 dpl. For
pharmacological treatments, 500 mM of Sp-8-pCPT-cAMPs and lysolecithin
were injected day 0, and harvested at 3 dpl and 7 dpl to assess the effect on
OLP differentiation. EM analysis was performed at 10 dpl as described in
Chang et al. (2010). Vehicle control experiments included co-injection of
lysolecithin with PBS.
Ex Vivo Cerebellar Slice Culture
Slice culture was performed as described previously (Birgbauer et al., 2004;
Fancy et al., 2011). Briefly, the sagittal slices of postnatal day 0–1 mouse cer-
ebellum were cut at 350 mM using a McIlwain tissue chopper, and the slices
were plated on Millicell-CM culture inserts (Millipore, 0.4 mm) in slice culture
medium (50% MEM with Earle’s salts, 35% Earle’s balanced salt solution,
25% heat-inactivated horse serum, glutamax, fungizone, penicillin-strepto-
mycin, and glucose) for up to 14–28 days at 37C.
HI and PB/IUE
HI was performed as described in Scafidi et al. (2014). P3 pups and nursing
mothers were placed in 10.5% oxygen for 8 days then returned to normoxia
until harvested at P18. IUE was performed as previously described in Chen
and LoTurco (2012); Dual PiggyBac system is also described in Chen and
LoTurco (2012) and Glasgow et al. (2014). Electroporation was performed at
embryonic day 15.
Human HIE Tissue
All human tissue was collected in accordance with guidelines established by
the University of California, San Francisco Committee on Human Research
(H11170-19113-07). The procurement of tissue and its pathological diagnosis
as HIE tissue has been described in detail previously (Fancy et al., 2011).
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